Back to Results
First PageMeta Content
Ribbon symbolism / Cancer treatments / Breast cancer / Mammary ductal carcinoma / Adjuvant therapy / Breast cancer classification / MammaPrint / Medicine / Oncology / Oncotype DX


Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta A Health Technology Assessment Simrandeep K Tiwana, Alison Smith, Laura Leggett, Gail MacKean, Dia
Add to Reading List

Document Date: 2014-08-23 02:59:48


Open Document

File Size: 1,49 MB

Share Result on Facebook

City

Ottawa / /

Company

Expert Advisory Group / /

Facility

University of Calgary August / /

IndustryTerm

health technology assessment / decision support tool / Treatment for invasive breast cancer / treatment decision support tool / /

MarketIndex

BRCA / /

MedicalCondition

invasive breast cancer / early invasive breast cancer / breast cancer / /

MedicalTreatment

chemotherapy / adjuvant chemotherapy / /

Movie

Conflict of Interest / /

Organization

University of Calgary / Ontario Health Technology Advisory Committee / Health Technology Assessment Unit / /

Person

Sasha Lupichuck / Gail MacKean / Charles Butts / Marc Webster / Kate Wagontall / Anna Sienko / Judith Hugh / Jean Deschenes / Diane Lorenzetti / Tammy Hofer / Douglas Perry / Jason Lau / Alison Smith / Alberta Perspective / Fiona Clement / Laura Leggett / Nina Buscemi / /

Position

General / model for health technology assessment and policy analysis / /

PublishedMedium

the Clinical Systematic Review / /

Technology

1.7 Technologies / Gene Expression / chemotherapy / /

SocialTag